Literature DB >> 12891940

[Hypophosphatemia in dialysis units].

M Albalate1, E Gruss, J Hernández, C Caramelo.   

Abstract

Hypophosphatemia (Hf) is infrequently reported in chronic hemodialysis patients. The objective of this report is to describe the incidence, etiology, symptoms and treatment of Hf in a Dialysis Unit (defined as phosphorus < 2.5 mg/dL). In a retrospective study over a period of three years, we identified 22 cases of Hf, occurring on 11 among 149 patients. A two-groups distribution was made: Group A, patients with more than one episode (n = 3, 14 episodes of Hf) and Group B, patients with only one isolated episode of Hf (n = 8, 8 episodes of Hf). Plasma Ca, P, Albumin and nPCR were significant lower in group A (p < 0.05). Only two patients of group B had symptoms. Cases of Hf were: Group A: low-protein diet and alcoholism, Group B: decreased dietary intake due to non-digestive problems (n = 2) or due to digestive problems plus antacids (n = 4), phos-phate binders (n = 1) and dietary phosphorus restriction (n = 1). Three patients had secondary hyperparathyroidism. Treatment consisted on oral supplementarion by diet and changes in oral calcium salts. Intravenous supplementation was required acutely to raise serum P in a patient with auricular fibrilation. Two group A patients who has plasma 1.25 vitamin D < 5 pg/mL received vitamin D, and the third oral supplements of P. In all the cases, Hf resolved with these measures. We concluded that Hf is not so infrequent in hemodialysis. In patients with low-protein diet and low vitamin D concentration, Hf can be sustained. On the other hand, a decreased dietary intake maintaining similar phosphate binder's supplementation is the most frequent cause of occasional and symptomatic Hf, even in patients with secondary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12891940

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  4 in total

1.  Hypophosphatemia: nutritional status, body composition, and mortality in hemodialysis patients.

Authors:  Cristina Garagarza; Ana Valente; Cristina Caetano; Telma Oliveira; Pedro Ponce; Ana Paula Silva
Journal:  Int Urol Nephrol       Date:  2017-03-06       Impact factor: 2.370

2.  Osteomalacia induced by vitamin D deficiency in hemodialysis patients: the crucial role of vitamin D correction.

Authors:  Fabrice Mac-Way; Linda Azzouz; Christian Noel; Marie-Hélène Lafage-Proust
Journal:  J Bone Miner Metab       Date:  2013-06-21       Impact factor: 2.626

Review 3.  Phosphate control in dialysis.

Authors:  Adamasco Cupisti; Maurizio Gallieni; Maria Antonietta Rizzo; Stefania Caria; Mario Meola; Piergiorgio Bolasco
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-10-04

4.  Dietary Advice in Hemodialysis Patients: Impact of a Telehealth Approach During the COVID-19 Pandemic.

Authors:  Ana Valente; Joana Jesus; Joana Breda; Ana Dinis; André Correia; Joana Godinho; Telma Oliveira; Cristina Garagarza
Journal:  J Ren Nutr       Date:  2021-05-05       Impact factor: 4.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.